We estimate that the President and CEO of PENTAIR plc ($PNR), John L. Stauch, received a compensation of $11,374,255 in 2025. This is an increase of 5.31% from an estimated $10,769,964 in 2024.
These estimates are based on a new DEF14A filing, filed with the SEC on March 20, 2026. Note that parsing errors may occur.
You can track $PNR on Quiver Quantitative's $PNR stock dashboard.
$PNR Stock Insider Trading Activity
$PNR Stock insiders have traded $PNR stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $PNR stock by insiders over the last 6 months:
- ROBERT P FISHMAN (EVP & Chief Financial Officer) has made 0 purchases and 8 sales selling 7,786 shares for an estimated $820,765.
- MICHAEL T SPEETZEN sold 7,000 shares for an estimated $699,945
- T MICHAEL GLENN sold 6,558 shares for an estimated $684,196
- PHILIP M. ROLCHIGO (EVP & Chief Technology Officer) sold 6,493 shares for an estimated $670,207
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$PNR Stock Congressional Stock Trading
Members of Congress have traded $PNR stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $PNR stock by members of Congress over the last 6 months:
- SENATOR MARKWAYNE MULLIN purchased up to $50,000 on 11/10.
- REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$PNR Stock Hedge Fund Activity
We have seen 335 institutional investors add shares of $PNR Stock stock to their portfolio, and 420 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 10,411,560 shares (-79.8%) from their portfolio in Q4 2025, for an estimated $1,084,259,858
- ALYESKA INVESTMENT GROUP, L.P. removed 738,358 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $81,780,532
- ASSENAGON ASSET MANAGEMENT S.A. added 688,921 shares (+1690.9%) to their portfolio in Q4 2025, for an estimated $71,744,232
- NORDEA INVESTMENT MANAGEMENT AB added 647,162 shares (+22.8%) to their portfolio in Q4 2025, for an estimated $67,395,450
- PICTET ASSET MANAGEMENT HOLDING SA removed 565,720 shares (-11.8%) from their portfolio in Q4 2025, for an estimated $58,914,080
- PACER ADVISORS, INC. removed 512,402 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $53,361,544
- ADAGE CAPITAL PARTNERS GP, L.L.C. removed 483,702 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $53,574,833
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$PNR Stock Analyst Ratings
Wall Street analysts have issued reports on $PNR in the last several months. We have seen 4 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Buy" rating on 01/12/2026
- BNP Paribas Exane issued a "Underperform" rating on 01/07/2026
- UBS issued a "Buy" rating on 10/22/2025
- RBC Capital issued a "Outperform" rating on 10/22/2025
- JP Morgan issued a "Overweight" rating on 10/15/2025
To track analyst ratings and price targets for $PNR Stock, check out Quiver Quantitative's $PNR forecast page.
$PNR Stock Price Targets
Multiple analysts have issued price targets for $PNR recently. We have seen 8 analysts offer price targets for $PNR in the last 6 months, with a median target of $123.0.
Here are some recent targets:
- Andrew Kaplowitz from Citigroup set a target price of $120.0 on 02/04/2026
- Bryan Blair from Oppenheimer set a target price of $122.0 on 02/04/2026
- Stephen Tusa from JP Morgan set a target price of $124.0 on 01/16/2026
- Joseph Giordano from TD Cowen set a target price of $90.0 on 01/05/2026
- Saree Boroditsky from Jefferies set a target price of $135.0 on 12/10/2025
- Julian Mitchell from Barclays set a target price of $115.0 on 12/04/2025
- Deane Dray from RBC Capital set a target price of $124.0 on 10/22/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.